New Real-World Clinical Evidence Confirms ProFound AI Boosts Radiologists’ Efficiency and Accuracy
01 mars 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., March 01, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new...
iCAD to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
09 févr. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Feb. 09, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company...
iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI
23 janv. 2023 08h00 HE
|
iCAD, Inc.
Daniel Shea appointed as interim Chief Financial Officer William Keyes hired as Senior Vice President, US Commercial Sales, AI NASHUA, N.H., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:...
iCAD Announces Board of Directors Transition
11 janv. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Jan. 11, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the...
iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinar
08 déc. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Dec. 08, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Solis...
iCAD and Google Health Ink Strategic Development and Commercialization Agreement
28 nov. 2022 08h00 HE
|
iCAD, Inc.
Google Health AI and Cloud technology to be integrated into iCAD’s portfolio with potential to elevate performance and expand access to millions of women worldwide Agreement marks Google Health’s...
Positive New Research Presented at RSNA 2022 Reaffirms iCAD’s Breast AI Suite Improves Radiologists’ Performance and Breast Cancer Detection
21 nov. 2022 08h00 HE
|
iCAD, Inc.
Study affirms utility of ProFound AI’s Case Scores in improving cancer detection Company’s Breast AI Suite of deep-learning breast cancer detection, density assessment and risk evaluation tools...
iCAD to Participate in the 13th Annual Craig-Hallum Alpha Select Conference
15 nov. 2022 16h13 HE
|
iCAD, Inc.
NASHUA, N.H., Nov. 15, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey...
iCAD to Present at HLTH 2022 With Google
14 nov. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Nov. 14, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced iCAD will...
iCAD Reports Financial Results for Third Quarter Ended September 30, 2022
10 nov. 2022 16h03 HE
|
iCAD, Inc.
Company implements corporate strategic realignment Partnership-based recurring revenue model anticipated to drive future growth Cost structure reduction to decrease expenses by over $3 million...